BIO-RAD LABORATORIES, INC. financial data

Symbol
BIO, BIO-B on NYSE
Location
Hercules, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 554% % -13%
Quick Ratio 149% % -9.5%
Debt-to-equity 43% % 3.6%
Return On Assets 7.6% %
Operating Margin 1.8% % -83%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 27,263,000 shares -3.4%
Weighted Average Number of Shares Outstanding, Diluted 27,281,000 shares -3.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,583,200,000 USD 0.65%
Research and Development Expense $275,600,000 USD -6.9%
Operating Income (Loss) $47,200,000 USD -82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $995,500,000 USD
Income Tax Expense (Benefit) $235,600,000 USD
Net Income (Loss) Attributable to Parent $759,900,000 USD
Earnings Per Share, Basic 27.87 USD/shares
Earnings Per Share, Diluted 27.85 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $529,800,000 USD 8.5%
Accounts Receivable, after Allowance for Credit Loss, Current $460,600,000 USD 1.8%
Inventory, Net $740,700,000 USD -2.5%
Other Assets, Current $27,700,000 USD -9.8%
Assets, Current $2,906,200,000 USD -4.1%
Property, Plant and Equipment, Net $539,900,000 USD 2.2%
Operating Lease, Right-of-Use Asset $170,000,000 USD 5.9%
Intangible Assets, Net (Excluding Goodwill) $174,300,000 USD -41%
Goodwill $579,800,000 USD 41%
Other Assets, Noncurrent $102,700,000 USD 0.78%
Assets $10,576,500,000 USD 13%
Accounts Payable, Current $129,000,000 USD 5.5%
Employee-related Liabilities, Current $172,300,000 USD 39%
Liabilities, Current $517,000,000 USD 11%
Long-term Debt and Lease Obligation $1,210,000,000 USD 0.8%
Deferred Income Tax Liabilities, Net $1,059,400,000 USD 30%
Operating Lease, Liability, Noncurrent $145,700,000 USD 11%
Other Liabilities, Noncurrent $199,100,000 USD 12%
Liabilities $3,122,900,000 USD 12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $189,100,000 USD 65%
Retained Earnings (Accumulated Deficit) $8,176,300,000 USD 10%
Stockholders' Equity Attributable to Parent $7,453,600,000 USD 13%
Liabilities and Equity $10,576,500,000 USD 13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,900,000 USD 86%
Net Cash Provided by (Used in) Financing Activities $97,700,000 USD
Net Cash Provided by (Used in) Investing Activities $2,900,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $33,300,000 USD 13%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $532,200,000 USD 8.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities $22,200,000 USD -0.89%
Deferred Tax Assets, Valuation Allowance $123,500,000 USD 30%
Deferred Tax Assets, Gross $285,500,000 USD 14%
Operating Lease, Liability $181,800,000 USD 5%
Payments to Acquire Property, Plant, and Equipment $34,400,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid $217,000,000 USD 11%
Property, Plant and Equipment, Gross $1,800,900,000 USD 10%
Operating Lease, Liability, Current $36,100,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $35,700,000 USD -4.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $42,500,000 USD -9.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.048 pure 17%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $35,200,000 USD 57%
Lessee, Operating Lease, Liability, to be Paid, Year Three $27,600,000 USD -3.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7,500,000 shares 0%
Unrecognized Tax Benefits $86,900,000 USD 0.23%
Lessee, Operating Lease, Liability, to be Paid, Year Four $22,500,000 USD 4.2%
Operating Lease, Payments $44,200,000 USD 3.3%
Additional Paid in Capital $476,000,000 USD 2.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $23,800,000 USD 12%
Deferred Tax Assets, Net of Valuation Allowance $162,000,000 USD 4%
Interest Expense $49,000,000 USD 0.2%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%